Ralph Bax

414 total citations
16 papers, 247 citations indexed

About

Ralph Bax is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Ralph Bax has authored 16 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Ralph Bax's work include Pharmaceutical studies and practices (9 papers), Neonatal Respiratory Health Research (3 papers) and Ethics and Legal Issues in Pediatric Healthcare (3 papers). Ralph Bax is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Neonatal Respiratory Health Research (3 papers) and Ethics and Legal Issues in Pediatric Healthcare (3 papers). Ralph Bax collaborates with scholars based in United States, United Kingdom and Netherlands. Ralph Bax's co-authors include Jürgen Heesemann, Marianne Abele‐Horn, Ulrich Busch, Hans Nitschko, Enno Jacobs, M. Turner, Jonathan M. Davis, S. J. Machin, Susan McCune and Ronald J. Portman and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Ralph Bax

15 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Bax United States	9	96	89	68	44	25	16	247
Alessandro Porta Italy	9	135 1.4×	53 0.6×	17 0.3×	53 1.2×	26 1.0×	17	320
Sina Helbig Germany	9	196 2.0×	72 0.8×	11 0.2×	18 0.4×	17 0.7×	20	306
Isabelle Chevalier Canada	8	99 1.0×	73 0.8×	11 0.2×	18 0.4×	37 1.5×	21	219
Panagiotis Georgakopoulos Greece	9	81 0.8×	53 0.6×	13 0.2×	12 0.3×	78 3.1×	26	235
Ladan Haghighi Iran	11	100 1.0×	130 1.5×	29 0.4×	49 1.1×	120 4.8×	53	323
Barbara Bortone Italy	7	50 0.5×	32 0.4×	9 0.1×	37 0.8×	45 1.8×	18	196
Jeffrey Pearl United States	10	45 0.5×	32 0.4×	17 0.3×	70 1.6×	34 1.4×	19	399
Esther H. Normand United States	5	253 2.6×	66 0.7×	8 0.1×	16 0.4×	25 1.0×	6	371
Cordula Lebert Germany	8	208 2.2×	88 1.0×	6 0.1×	23 0.5×	11 0.4×	13	280
Enav Yefet Israel	15	65 0.7×	150 1.7×	32 0.5×	26 0.6×	85 3.4×	55	517

Countries citing papers authored by Ralph Bax

Since Specialization

Citations

This map shows the geographic impact of Ralph Bax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Bax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Bax more than expected).

Fields of papers citing papers by Ralph Bax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Bax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Bax. The network helps show where Ralph Bax may publish in the future.

Co-authorship network of co-authors of Ralph Bax

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Bax. A scholar is included among the top collaborators of Ralph Bax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Bax. Ralph Bax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Andrés-Trelles, F, Ralph Bax, Sara Galluzzo, et al.. (2025). New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development. Frontiers in Medicine. 12. 1583140–1583140.

Bax, Ralph, Andrea Gropman, Anne Pariser, et al.. (2022). Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases. Therapeutic Innovation & Regulatory Science. 56(6). 964–975. 16 indexed citations

Karres, Dominik, Gregory H. Reaman, Franca Ligas, et al.. (2021). Common Commentary on Paediatric Oncology Drug Development Published: Another Step in Optimising Global Regulatory Coordination of Paediatric Development Plans. Therapeutic Innovation & Regulatory Science. 55(6). 1109–1110. 4 indexed citations

Slater, Rebeccah, Fiona Moultrie, Ralph Bax, John van den Anker, & Aomesh Bhatt. (2020). Preterm health: time to bridge the evidence gap. The Lancet. 396(10255). 872–873. 15 indexed citations

Baum, Victor C., et al.. (2019). Pediatric drug regulation: International perspectives. Pediatric Anesthesia. 29(6). 572–582. 10 indexed citations

Davis, Jonathan M., Gerri Baer, Ronald J. Portman, et al.. (2017). Enrollment of Neonates in More Than One Clinical Trial. Clinical Therapeutics. 39(10). 1959–1969. 11 indexed citations

Turner, M., Jonathan M. Davis, Susan McCune, et al.. (2016). The International Neonatal Consortium: collaborating to advance regulatory science for neonates. Pediatric Research. 80(4). 462–464. 32 indexed citations

Offringa, Martin, Jonathan M. Davis, M. Turner, et al.. (2015). Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014. Therapeutic Innovation & Regulatory Science. 49(5). 623–631. 7 indexed citations

Samardžić, Janko, M. Turner, Ralph Bax, & Karel Allegaert. (2015). Neonatal medicines research: challenges and opportunities. Expert Opinion on Drug Metabolism & Toxicology. 11(7). 1041–1052. 11 indexed citations

10.

Abele‐Horn, Marianne, Ulrich Busch, Hans Nitschko, et al.. (1998). Molecular Approaches to Diagnosis of Pulmonary Diseases Due to Mycoplasma pneumoniae. Journal of Clinical Microbiology. 36(2). 548–551. 97 indexed citations

11.

Williams, Keith J., et al.. (1991). Antibiotic treatment and associated prolonged prothrombin time.. Journal of Clinical Pathology. 44(9). 738–741. 9 indexed citations

12.

Bax, Ralph, et al.. (1989). The role of the pharmaceutical industry in the prevention and control of ascariasis.. 275–288. 1 indexed citations

13.

Bax, Ralph. (1988). Clinical trials and the pharmaceutical industry. Journal of Antimicrobial Chemotherapy. 21(3). 278–280. 2 indexed citations

14.

Cohen, Hannah, Simon D. Scott, Ian Mackie, et al.. (1988). The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K₁ levels. British Journal of Haematology. 68(1). 63–66. 26 indexed citations

15.

Cohen, Hannah, Ian Mackie, Martin J. Shearer, et al.. (1987). The effects of cefotetan disodium on haemostatis. Journal of Hospital Infection. 10(1). 51–57. 5 indexed citations

16.

Bax, Ralph, et al.. (1982). The Diploma in Pharmaceutical Medicine. Journal of the Royal College of Physicians of London. 16(2). 105–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact